Header Logo

Connection

RONG CHEN to Treatment Outcome

Back to Details
This is a "connection" page, showing publications RONG CHEN has written about Treatment Outcome.
RONG CHEN
Connection Strength
0.005
Treatment Outcome
  1. Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma. J Clin Oncol. 2010 Jun 20; 28(18):3015-22.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.